Isothermal Nucleic Acid Amplification Technologies Market 2012-2017: Molecular Diagnostics, Infectious Disease Testing, Blood Screening, Cancer Research, Rapid Testing

DUBLIN, April 15, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Isothermal Nucleic Acid Amplification Technologies Market 2012-2017: Molecular Diagnostics, Infectious Disease Testing, Blood Screening, Cancer Research, Rapid Testing" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Isothermal Nucleic Acid Amplification Technologies (INAAT) discloses the promising trends in Nucleic acid testing and their applications in molecular diagnostics and laboratory research on a global scale. The World Health Organization (WHO) proposes that, an ideal diagnostic test that is suitable for developing countries, should be Affordable, Sensitive, Specific and User-friendly (simple to perform in a few steps with minimal training), Robust and rapid (results available in minutes), Equipment free and Deliverable to the end user (ASSURED). Nucleic acid amplification tests targeting pathogen markers have high sensitivity and specificity, but generally fail to meet the ASSURED guidelines in terms of affordability, rapidity, and being equipment free. However, INAAT has recently attracted the scientific community due to their operation in single temperature and distinct features by meeting the ASSURED guidelines. With fine-tunings in the amplification methodology, a variety of INAAT types are discovered each being independent, driving the diagnostic platform towards Point-Of-Care (POC) testing at low resource settings.

This research report provides in-depth details about technology evolution, and innovation trends across the industry, technology investment potential and competitive market landscape. The analyses ensuing out of this research service may provide, useful insights for end users, while prioritizing the appropriate choice of modality for nucleic acid testing in research and diagnostics.

In brief, this research report provides:

A detailed description of the global technology developments and evolving trends, in the INAAT field with key prominence on product innovations by industries, and collaborative efforts by the academic research institutions.

A comprehensive picture of the different types of INAAT platforms available with an exhaustive overview of their application prospective.

• An impact analysis of major drivers, restraints and challenges influencing the adoption and growth of INAAT during the period from 2012 to 2017.
• Market size - Global market forecast for the next 5 years, including demand side analysis and strategic recommendations for technology/product developers.
• Prioritized INNAT types through the Analytical Hierarchy Process (AHP) based on competitive benchmarking, technology management strategies and technology roadmap.

Competitive landscape based on the analysis of key patents and research publications that gives an insight into prominent activities and global participants.

Main Driver:

Global prevalence of infections and cancer: An effective diagnosis of diseases is the first step towards personalized medicine. Over 1 billion people are afflicted owing to infectious diseases and cancer especially in the tropical/developing countries where access to diagnostics labs are limited.

Main Restraint:

Conservative mindset for INAAT usage: Most of the end users perceive PCR to be more reliable standard for detection. This is true for some of the developing and developed countries. Owing to the lack of knowledge or awareness about the advances in the latest technological developments in INAAT. This is perceived as a restraint for INAAT market

Main Challenge:

Market penetration of INAAT: Penetrating new markets in China, India and Middle could be competitive for INAAT based players due to high competition from players who are already suppliers of PCR based products. However this could be a big advantage for PCR diagnostic product manufacturers, since they have capability to adopt these new technologies.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Isothermal Nucleic Acid Amplification Technologies (INAAT) - Technology Landscape Analysis

4 Technology Investment Potential

5 INAAT - Market Landscape Analysis

6 INAAT - Technology Adoption Potential & Development By Geography

7 Competitive Landscape

8 Patent Analysis And Research Trend (Publications) 2007-2012

9 TECHNOLOGY ANALYSIS (USING AHP) & ROAD MAPPING

10 Analyst Insights & Recommendations

11 Company Profiles

- BECTON, DICKINSON AND COMPANY (BD)
- BIOHELIX
- BIOMERIEUX
- EIKEN CHEMICAL CO., LTD.
- HOLOGIC GEN-PROBE
- LUCIGEN
- MERIDIAN BIOSCIENCE INC
- NEW ENGLAND BIOLABS
- NOVARTIS DIAGNOSTICS
- NUGEN
- QIAGEN
- TWISTDX
- USTAR BIOTECHNOLOGIES (HANGZHOU) LTD.

For more information visit Isothermal Nucleic Acid Amplification Technologies Market 2012-2017: Molecular Diagnostics, Infectious Disease Testing, Blood Screening, Cancer Research, Rapid Testing

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets.

Research and Markets
Laura Wood, Senior Manager.
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets